Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Allogeneic Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00506857
What this trial is testing

Phase I/II Trial of Fludarabine Plus Busulfan and Allogeneic Progenitor Cell Support

Who this might be right for
Hematologic Malignancies
M.D. Anderson Cancer Center 82
Testing effectiveness (Phase 2)UnknownNCT02385019
What this trial is testing

A Phase 1/2 Trial of Donor Regulatory T-cells for Steroid-Refractory Chronic Graft-versus-Host-Disease

Who this might be right for
Graft vs Host Disease
Instituto de Medicina Molecular João Lobo Antunes 22
Testing effectiveness (Phase 2)Ended earlyNCT04200365
What this trial is testing

Itacitinib for the Treatment of Chronic Graft Versus Host Disease (cGVHD)

Who this might be right for
Chronic Graft-versus-host-disease
SCRI Development Innovations, LLC 15
Early research (Phase 1)Study completedNCT03393611
What this trial is testing

CPX-351 Salvage Therapy Followed by Haplo-Cord Transplant for Relapsed/Refractory Leukemia or Myelodysplastic Syndrome

Who this might be right for
Myelodysplastic SyndromesLeukemia, Myeloid, AcuteLeukemia, Relapsed Adult Acute Myeloid+1 more
Weill Medical College of Cornell University 14
Testing effectiveness (Phase 2)Study completedNCT00599495
What this trial is testing

Matched Unrelated Donor Stem Cell Transplantation (MUD-SCT) After Dose-reduced Conditioning for Patients With Multiple Myeloma and Relapse After Autologous SCT

Who this might be right for
Multiple Myeloma
Universitätsklinikum Hamburg-Eppendorf 50
Testing effectiveness (Phase 2)UnknownNCT06468267
What this trial is testing

RIC With Thiotepa Combined With Bu/Flu/Ara-C in Allo-HSCT for Relapsed or Refractory PTCL.

Who this might be right for
Peripheral T Cell Lymphoma
Xianmin Song, MD 50
Testing effectiveness (Phase 2)Study completedNCT00448357
What this trial is testing

Allogeneic Hematopoietic Cell Transplantation for Patients With Busulfex-based Regimen

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+2 more
UNC Lineberger Comprehensive Cancer Center 54
Not applicableNot Yet RecruitingNCT06386445
What this trial is testing

Study on the Serum Metabolic Markers and Early Complications After Allo-HSCT： Cohort Study

Who this might be right for
Stem Cell Transplant ComplicationsAcute Graft Versus Host DiseaseAcute Kidney Injury+1 more
First Affiliated Hospital Xi'an Jiaotong University 500
Early research (Phase 1)Looking for participantsNCT06313957
What this trial is testing

LUCAR-20SP in Subjects With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

Who this might be right for
Relapsed B-cell Non-Hodgkin LymphomaRefractory B-cell Non-Hodgkin Lymphoma
Peking University Cancer Hospital & Institute 42
Early research (Phase 1)Study completedNCT00677222
What this trial is testing

Safety Study of AMI MultiStem® to Treat Heart Attacks

Who this might be right for
Acute Myocardial Infarction
Healios K.K. 25
Testing effectiveness (Phase 2)Study completedNCT00505895
What this trial is testing

FM 140 vs FM100 Study in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
M.D. Anderson Cancer Center 52
Testing effectiveness (Phase 2)Study completedNCT00003195
What this trial is testing

Total-Body Irradiation, Busulfan, and Interferon Alfa Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00002547
What this trial is testing

Chemotherapy and Bone Marrow Transplantation in Treating Patients Acute Myeloid With Leukemia or Myelodysplastic Syndrome

Who this might be right for
LeukemiaMyelodysplastic Syndromes
Barbara Ann Karmanos Cancer Institute 280
Not applicableStudy completedNCT03910478
What this trial is testing

Dried Blood Spot Testing of CMV Detection in HCT Recipients

Who this might be right for
Cytomegalovirus Infection
National Institute of Allergy and Infectious Diseases (NIAID) 622
Testing effectiveness (Phase 2)Study completedNCT02687646
What this trial is testing

Clinical Trial With MSC for Graft Versus Host Disease Treatment

Who this might be right for
Acute Graft Versus Host Disease
Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud 16
Early research (Phase 1)WithdrawnNCT02786485
What this trial is testing

Study of Matched Unrelated Donor T Cell Infusion for Hematologic Malignancies After Allo-HSCT

Who this might be right for
LeukemiaMyelodysplastic SyndromesLymphomas+2 more
Bellicum Pharmaceuticals
Large-scale testing (Phase 3)Ended earlyNCT01339910
What this trial is testing

Reduced Intensity Regimen vs Myeloablative Regimen for Myeloid Leukemia or Myelodysplastic Syndrome (BMT CTN 0901)

Who this might be right for
Leukemia, Myelocytic, Acute
Medical College of Wisconsin 272
Testing effectiveness (Phase 2)Study completedNCT01181258
What this trial is testing

Penostatin, Rituximab and Ontak and Allogeneic Natural Killer (NK) Cells for Refractory Lymphoid Malignancies

Who this might be right for
Non-Hodgkin LymphomaChronic Lymphocytic Leukemia
Masonic Cancer Center, University of Minnesota 16
Testing effectiveness (Phase 2)Study completedNCT02308280
What this trial is testing

Nonmyeloablative Allogeneic Stem Cell Transplant Followed by Bortezomib in High-risk Multiple Myeloma Patients

Who this might be right for
Multiple MyelomaHigh-Risk Cancer
Maisonneuve-Rosemont Hospital 40
Testing effectiveness (Phase 2)UnknownNCT02507479
What this trial is testing

Thiotepa-based Conditioning for Allogeneic Stem-cell Transplantation (SCT) in Lymphoid Malignancies

Who this might be right for
Non Hodgkin LymphomaHodgkin LymphomaChronic Lymphocytic Leukemia+1 more
Sheba Medical Center 24
Next Page